Osteoporosis: assessing and managing patients at low, high, and very high risk
Dr David Stephens introduces a consensus guideline to assist primary care in the assessment, management, and treatment of osteoporosis
Pregnancy and rheumatic diseases: best practice and prescribing considerations
Professor Ian Giles and Professor Caroline Gordon describe best practice in the care of women of child-bearing age with inflammatory rheumatic diseases before, during, and after pregnancy
Top tips: joint pain
Dr Louise Warburton offers 10 top tips on the diagnosis and management of joint pain in primary care
Osteoporosis: target treatment on the basis of fracture risk
Dr David Stephens summarises new recommendations from the updated SIGN guideline on the management of osteoporosis and prevention of fragility fractures
People with suspected rheumatoid arthritis must be referred urgently
Dr Louise Warburton reviews the latest recommendations from NICE on the management of rheumatoid arthritis in adults
Test and reflect
Our multiple-choice questions (MCQs) are designed to help you test your knowledge and reflect on your learning after reading an article.
Educational resources
The unrecognised epidemic of vitamin D deficiency in Black, Asian and Minority Ethnic (BAME) groups: a consensus document
Information intended for UK healthcare professionals only. This supplement has been commissioned and funded by STADA incorporating Thornton & Ross, who provided the content.
TR-088d Date of preparation: August 2021
NICE Technology Appraisal 719: Secukinumab for treating non-radiographic axial spondyloarthritis
The production of this Guidelines card has been commissioned by Novartis Pharmaceuticals UK Ltd.
View Cosentyx (secukinumab) prescribing and adverse event reporting information
MLR ID 147195 August 2021
Methofill® (methotrexate) SelfDose for the treatment of adult patients with rheumatoid arthritis, Crohn’s disease, and psoriasis*
Intended for UK Healthcare professionals only.
This promotional supplement has been commissioned and funded by Accord-UK Ltd and developed in partnership with Guidelines in Practice.
Click here for Methofill® (methotrexate) prescribing information and adverse event reporting
For full indications, please consult the summary of product characteristics.
UK-03037 | Date of preparation: May 2021
Romosozumab▼ (Evenity®) 105mg solution for injection in prefilled pen SMC2280
The production of this Guidelines card has been commissioned by UCB Pharma Ltd.
Amgen and UCB Pharma Ltd are co-developing Evenity®.
View prescribing information and adverse event reporting
UK-P-RM-OP-2000095 December 2020
Osteoarthritis-related pain
PP-PPF-GBR-0130 Date of preparation: June 2021
